Landscape Capital Management L.L.C. bought a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN – Free Report) in the third quarter, HoldingsChannel.com reports. The firm bought 135,345 shares of the company’s stock, valued at approximately $1,218,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Parkside Financial Bank & Trust increased its holdings in shares of Haleon by 20.4% in the 2nd quarter. Parkside Financial Bank & Trust now owns 6,233 shares of the company’s stock valued at $58,000 after acquiring an additional 1,055 shares during the period. Bessemer Group Inc. lifted its stake in shares of Haleon by 4.8% during the 3rd quarter. Bessemer Group Inc. now owns 25,659 shares of the company’s stock worth $232,000 after purchasing an additional 1,185 shares during the last quarter. Sterling Capital Management LLC lifted its stake in shares of Haleon by 1.9% during the 3rd quarter. Sterling Capital Management LLC now owns 88,039 shares of the company’s stock worth $792,000 after purchasing an additional 1,624 shares during the last quarter. Ethic Inc. lifted its stake in shares of Haleon by 1.5% during the 3rd quarter. Ethic Inc. now owns 111,428 shares of the company’s stock worth $1,003,000 after purchasing an additional 1,658 shares during the last quarter. Finally, Diversify Advisory Services LLC boosted its position in Haleon by 7.7% during the third quarter. Diversify Advisory Services LLC now owns 24,023 shares of the company’s stock valued at $239,000 after purchasing an additional 1,711 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.
Haleon Stock Performance
Shares of HLN stock opened at $9.04 on Friday. The business’s fifty day simple moving average is $9.32 and its 200-day simple moving average is $9.69. The company has a market cap of $39.76 billion, a PE ratio of 23.19, a PEG ratio of 2.13 and a beta of 0.15. The company has a current ratio of 0.69, a quick ratio of 0.52 and a debt-to-equity ratio of 0.38. Haleon PLC Sponsored ADR has a 12-month low of $8.38 and a 12-month high of $11.28.
Analysts Set New Price Targets
Several research firms have issued reports on HLN. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research note on Thursday, August 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Friday, September 25th. Deutsche Bank raised shares of Haleon from a “sell” rating to a “hold” rating in a research report on Friday, October 30th. Wall Street Zen cut shares of Haleon from a “buy” rating to a “hold” rating in a report on Saturday, October 3rd. Finally, Zacks Research downgraded shares of Haleon from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $4.90.
Check Out Our Latest Analysis on HLN
Haleon Profile
Haleon plc is a global consumer healthcare company that develops and sells nonprescription health products. Its portfolio spans oral health, pain relief, vitamins and supplements, respiratory health, digestive health, and therapeutic skin care. Its brands include Sensodyne, parodontax and Polident in oral care; Advil, Panadol and Voltaren for pain relief; and Centrum, Emergen-C and Theraflu in supplements and respiratory care. Haleon sells its products in markets around the world. Haleon became an independent public company in 2022 after separating from GSK.
Read More
- Five stocks we like better than Haleon
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
